Piperacillin Sodium and Tazobactam Sodium for Injection
Formulation (FDF) · for Injection · 0.5g: 0.125g; 1.0g: 0.25g; 2.0g: 0.5g; 0.5g: 0.0625g; 1.0g: 0.125g; 2.0g: 0.25g; 3.0g; 0.375g; 4.0g: 0.5g
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Piperacillin Sodium and Tazobactam Sodium for Injection
- Dosage Form
- for Injection
- Strength
- 0.5g: 0.125g; 1.0g: 0.25g; 2.0g: 0.5g; 0.5g: 0.0625g; 1.0g: 0.125g; 2.0g: 0.25g; 3.0g; 0.375g; 4.0g: 0.5g
- Therapy Area
- Infectious Diseases
- Indication
- Appendicitis; Peritonitis; Skin infection; Soft tissue infection; Cellulitis; Skin abscess; Foot infection; Endometritis; Pelvic inflammatory disease; Community acquired pneumonia; Nosocomial pneumonia; Bacterial infection
- Current Status
- Official FDF licensing catalog (UB274)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price